United States (US) Neuropathic Pain Market (2025-2031) | Trends, Companies, Competitive Landscape, Industry, Value, Forecast, Share, Outlook, Growth, Size & Revenue, Analysis, Segmentation
Market Forecast By Type (Spinal Cord Stimulation (SCS) Devices, External Peripheral Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation (Tens) Devices), By Product Type (Rechargeable and Non-Rechargeable), By Procedure (Invasive and Non-Invasive), By Technology (Transcutaneous Electrical Nerve Stimulation, Transcranial Magnetic Stimulation, Respiratory Electrical Stimulation), By Modality (Stationary, Portable), By Mode of Purchase (Over-the-Counter Devices, Prescription-Based Devices), By Pain Type (Peripheral Neuropathy, Entrapment Neuropathy, Phantom Limb Neuropathy, Trigeminal Neuralgia, Post Herpetic Neuralgia (PHN), Post Traumatic Neuropathy, Foot Pain, Coccydynia), By Indication (Spinal Stenosis, Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Others) And Competitive Landscape
| Product Code: ETC9971394 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Key Highlights of the Report:
- United States (US) Neuropathic Pain Market Outlook
- Market Size of United States (US) Neuropathic Pain Market, 2024
- Forecast of United States (US) Neuropathic Pain Market, 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Revenues & Volume for the Period 2021- 2031
- United States (US) Neuropathic Pain Market Trend Evolution
- United States (US) Neuropathic Pain Market Drivers and Challenges
- United States (US) Neuropathic Pain Price Trends
- United States (US) Neuropathic Pain Porter's Five Forces
- United States (US) Neuropathic Pain Industry Life Cycle
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Spinal Cord Stimulation (SCS) Devices for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By External Peripheral Nerve Stimulation for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Transcutaneous Electrical Nerve Stimulation (Tens) Devices for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Product Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Rechargeable and Non-Rechargeable for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Procedure for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Invasive and Non-Invasive for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Technology for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Transcutaneous Electrical Nerve Stimulation for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Transcranial Magnetic Stimulation for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Respiratory Electrical Stimulation for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Modality for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Stationary for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Portable for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Mode of Purchase for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Over-the-Counter Devices for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Prescription-Based Devices for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Pain Type for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Peripheral Neuropathy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Entrapment Neuropathy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Phantom Limb Neuropathy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Trigeminal Neuralgia for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Post Herpetic Neuralgia (PHN) for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Post Traumatic Neuropathy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Foot Pain for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Coccydynia for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Indication for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Spinal Stenosis for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Chemotherapy-Induced Peripheral Neuropathy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Diabetic Neuropathy for the Period 2021- 2031
- Historical Data and Forecast of United States (US) Neuropathic Pain Market Revenues & Volume By Others for the Period 2021- 2031
- United States (US) Neuropathic Pain Import Export Trade Statistics
- Market Opportunity Assessment By Type
- Market Opportunity Assessment By Product Type
- Market Opportunity Assessment By Procedure
- Market Opportunity Assessment By Technology
- Market Opportunity Assessment By Modality
- Market Opportunity Assessment By Mode of Purchase
- Market Opportunity Assessment By Pain Type
- Market Opportunity Assessment By Indication
- United States (US) Neuropathic Pain Top Companies Market Share
- United States (US) Neuropathic Pain Competitive Benchmarking By Technical and Operational Parameters
- United States (US) Neuropathic Pain Company Profiles
- United States (US) Neuropathic Pain Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
6Wresearch actively monitors the United States (US) Neuropathic Pain Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Neuropathic Pain Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Neuropathic Pain Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Neuropathic Pain Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Neuropathic Pain Market - Industry Life Cycle |
3.4 United States (US) Neuropathic Pain Market - Porter's Five Forces |
3.5 United States (US) Neuropathic Pain Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Neuropathic Pain Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 United States (US) Neuropathic Pain Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.8 United States (US) Neuropathic Pain Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.9 United States (US) Neuropathic Pain Market Revenues & Volume Share, By Modality, 2021 & 2031F |
3.10 United States (US) Neuropathic Pain Market Revenues & Volume Share, By Mode of Purchase, 2021 & 2031F |
3.11 United States (US) Neuropathic Pain Market Revenues & Volume Share, By Pain Type, 2021 & 2031F |
4 United States (US) Neuropathic Pain Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as diabetes contributing to neuropathic pain cases |
4.2.2 Growing aging population in the United States leading to higher incidence of neuropathic pain |
4.2.3 Advancements in healthcare technology and treatment options for neuropathic pain |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of neuropathic pain treatments |
4.3.2 High cost associated with neuropathic pain management |
4.3.3 Limited awareness among healthcare professionals about effective neuropathic pain management strategies |
5 United States (US) Neuropathic Pain Market Trends |
6 United States (US) Neuropathic Pain Market, By Types |
6.1 United States (US) Neuropathic Pain Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Neuropathic Pain Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Neuropathic Pain Market Revenues & Volume, By Spinal Cord Stimulation (SCS) Devices, 2021- 2031F |
6.1.4 United States (US) Neuropathic Pain Market Revenues & Volume, By External Peripheral Nerve Stimulation, 2021- 2031F |
6.1.5 United States (US) Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (Tens) Devices, 2021- 2031F |
6.2 United States (US) Neuropathic Pain Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Neuropathic Pain Market Revenues & Volume, By Rechargeable and Non-Rechargeable, 2021- 2031F |
6.3 United States (US) Neuropathic Pain Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Neuropathic Pain Market Revenues & Volume, By Invasive and Non-Invasive, 2021- 2031F |
6.4 United States (US) Neuropathic Pain Market, By Technology |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Neuropathic Pain Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation, 2021- 2031F |
6.4.3 United States (US) Neuropathic Pain Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.4.4 United States (US) Neuropathic Pain Market Revenues & Volume, By Respiratory Electrical Stimulation, 2021- 2031F |
6.5 United States (US) Neuropathic Pain Market, By Modality |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Neuropathic Pain Market Revenues & Volume, By Stationary, 2021- 2031F |
6.5.3 United States (US) Neuropathic Pain Market Revenues & Volume, By Portable, 2021- 2031F |
6.6 United States (US) Neuropathic Pain Market, By Mode of Purchase |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Neuropathic Pain Market Revenues & Volume, By Over-the-Counter Devices, 2021- 2031F |
6.6.3 United States (US) Neuropathic Pain Market Revenues & Volume, By Prescription-Based Devices, 2021- 2031F |
6.7 United States (US) Neuropathic Pain Market, By Pain Type |
6.7.1 Overview and Analysis |
6.7.2 United States (US) Neuropathic Pain Market Revenues & Volume, By Peripheral Neuropathy, 2021- 2031F |
6.7.3 United States (US) Neuropathic Pain Market Revenues & Volume, By Entrapment Neuropathy, 2021- 2031F |
6.7.4 United States (US) Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.5 United States (US) Neuropathic Pain Market Revenues & Volume, By Trigeminal Neuralgia, 2021- 2031F |
6.7.6 United States (US) Neuropathic Pain Market Revenues & Volume, By Post Herpetic Neuralgia (PHN), 2021- 2031F |
6.7.7 United States (US) Neuropathic Pain Market Revenues & Volume, By Post Traumatic Neuropathy, 2021- 2031F |
6.7.8 United States (US) Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.7.9 United States (US) Neuropathic Pain Market Revenues & Volume, By Coccydynia, 2021- 2031F |
6.8 United States (US) Neuropathic Pain Market, By Indication |
6.8.1 Overview and Analysis |
6.8.2 United States (US) Neuropathic Pain Market Revenues & Volume, By Spinal Stenosis, 2021- 2031F |
6.8.3 United States (US) Neuropathic Pain Market Revenues & Volume, By Chemotherapy-Induced Peripheral Neuropathy, 2021- 2031F |
6.8.4 United States (US) Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
6.8.5 United States (US) Neuropathic Pain Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Neuropathic Pain Market Import-Export Trade Statistics |
7.1 United States (US) Neuropathic Pain Market Export to Major Countries |
7.2 United States (US) Neuropathic Pain Market Imports from Major Countries |
8 United States (US) Neuropathic Pain Market Key Performance Indicators |
8.1 Average wait time for neuropathic pain diagnosis and treatment |
8.2 Patient satisfaction scores with neuropathic pain management services |
8.3 Number of clinical trials for new neuropathic pain treatments |
8.4 Adoption rates of innovative neuropathic pain management techniques |
8.5 Rate of hospital readmissions for neuropathic pain-related issues |
9 United States (US) Neuropathic Pain Market - Opportunity Assessment |
9.1 United States (US) Neuropathic Pain Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Neuropathic Pain Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 United States (US) Neuropathic Pain Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.4 United States (US) Neuropathic Pain Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.5 United States (US) Neuropathic Pain Market Opportunity Assessment, By Modality, 2021 & 2031F |
9.6 United States (US) Neuropathic Pain Market Opportunity Assessment, By Mode of Purchase, 2021 & 2031F |
9.7 United States (US) Neuropathic Pain Market Opportunity Assessment, By Pain Type, 2021 & 2031F |
9.7 United States (US) Neuropathic Pain Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 United States (US) Neuropathic Pain Market - Competitive Landscape |
10.1 United States (US) Neuropathic Pain Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Neuropathic Pain Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Global Go To Market Strategy - 2030
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here
Request Primary Research & Report
- Single User License$ 1,995
- Department License$ 2,400
- Site License$ 3,120
- Global License$ 3,795
Leadership Perspectives from Industry Events
Search
6Wresearch in the News
Forbes
Citing 6Wresearch analytics to map global infrastructure and pharmaceutical industry trajectories.
Bloomberg Law
Direct syndication of 6Wresearch's macro data points, capturing complex supply chain shifts.
Reuters
Tracking industrial manufacturing adjustments and electronic security ecosystem scaling.
Mint
Utilizing deep-tech sector market sizing to analyze global automation and robotics.
The Economic Times
Anchoring features on industrial IoT growth metrics and connected smart-grid devices.
Business Standard
Featuring strategic evaluations of Advanced Driver Assistance Systems (ADAS) and AI road safety.
The Hindu
Spotlighting core commercial metrics ranging from unmanned aerial vehicles (UAVs) to consumer durables.
Financial Express
Anchoring quarterly reviews on cross-border real estate tech and structural hardware manufacturing.
Yahoo Finance
Syndicating the tracker's $30.1 billion untapped-market findings, spotlighting Japan, the US and China as India's top new-potential importers.
India Today
Carrying the release on smartphones leading India's export potential to $94 billion by 2031, per 6WExportGTM data.
Dailyhunt
Distributing the tracker findings to its regional readership, framing India's export diversification into Japan and Mexico.
PR Newswire Original release
Publishing the full India Export Attractiveness Tracker 2026, detailing new trade corridors across iron ore, LCVs and pharmaceuticals.
The Industrial
Highlighting the tracker's read on India's semiconductor ambitions and long-term chip-assembly export potential.
PTI News
Reporting on the $66.81 billion pharmaceuticals export opportunity flagged in the tracker, amid looming US generic-drug tariffs.
Tribune India
Covering the tracker's tariff-versus-regulation analysis across India's mature export markets in the US, China and UAE.
ANI News
Amplifying the report's findings on polished diamonds, refined petroleum and medicines as India's core export engines.
International Business Magazine
Covering the report's insight into how AEB, blind spot detection, and driver monitoring are reshaping India's ADAS market.
Focus Gaming News
Highlighting the research forecast for Egypt's gambling market, projecting steady growth through 2032.
Thought Leadership and Analyst Meet
Our Clients
Latest Reports
- Namibia Financial Asset Management Market (2026-2032)
- Mozambique Financial Asset Management Market (2026-2032)
- Montenegro Financial Asset Management Market (2026-2032)
- Mongolia Financial Asset Management Market (2026-2032)
- Monaco Financial Asset Management Market (2026-2032)
- Micronesia Financial Asset Management Market (2026-2032)
- Mauritius Financial Asset Management Market (2026-2032)
- Mauritania Financial Asset Management Market (2026-2032)
- Marshall Islands Financial Asset Management Market (2026-2032)
- Malta Financial Asset Management Market (2026-2032)
Industry Events and Analyst Meet
EV India Expo 2026
HIMTEX 2026
India Refining Summit 2026
India EV Show 2026
EV tech India Expo 2026
Whitepaper
- Middle East & Africa Commercial Security Market Click here to view more.
- Middle East & Africa Fire Safety Systems & Equipment Market Click here to view more.
- GCC Drone Market Click here to view more.
- Middle East Lighting Fixture Market Click here to view more.
- GCC Physical & Perimeter Security Market Click here to view more.
